CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 12684 [2023-04044]

Download as PDF 12684 Federal Register / Vol. 88, No. 39 / Tuesday, February 28, 2023 / Notices pertinent contract. Contractors required to submit certified cost or pricing data in connection with a pricing action under a contract must make all records available to the contracting officer, or its authorized representative, including computations and projections related to the proposal for the contract, subcontract, or modification; the discussions conducted on the proposal(s), including those related to negotiating; pricing of the contract, subcontract, or modification; or performance of the contract, subcontract or modification. Also, this clause requires contractors to make all records available to the Comptroller General of the United States, or an authorized representative, to examine any of the contractor’s directly pertinent records involving transactions under the pertinent contract or subcontract. This clause allows the Comptroller General to interview any current employee regarding such transactions. The information must be retained so that audits necessary for contract surveillance, verification of contract pricing, and reimbursement of contractor costs can be performed. This information collection does not require contractors to create or maintain any record that the contractor does not maintain in its ordinary course of business. C. Annual Burden Respondents: 19,033. Total Annual Responses: 93,578. Total Burden Hours: 93,578. D. Public Comment ddrumheller on DSK120RN23PROD with NOTICES A 60-day notice was published in the Federal Register at 87 FR 77613, on December 19, 2022. No comments were received. Obtaining Copies: Requesters may obtain a copy of the information collection documents from the GSA Regulatory Secretariat Division, by calling 202–501–4755 or emailing GSARegSec@gsa.gov. Please cite OMB Control No. 9000–0034, Examination of Records by Comptroller General and Contract Audit, in all correspondence. Janet Fry, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2023–04039 Filed 2–27–23; 8:45 am] BILLING CODE 6820–EP–P VerDate Sep<11>2014 18:37 Feb 27, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC). This meeting is open to the public, limited only by the number of audio and web conference lines (1,000 audio and web conference lines are available). Members of the public are welcome to listen to the meeting by accessing the telephone number and web access provided in the addresses section below. Time will be available for public comment (registration is required to provide oral comment). DATES: The meeting will be held on April 18 and 19, 2023, from 9 a.m. to 4:30 p.m., EDT. Written comments must be submitted by April 28, 2023. Registration to make oral comments must be submitted by April 4, 2023. ADDRESSES: The telephone access number is 1–669–254–5252, Webinar ID: 160 343 1340, and the Passcode is 59009399. The web conference access is https://cdc.zoomgov.com/j/ 1603431340?pwd=VnB3SmRrRFA0OW F2bUpVMGgzbW51QT09, and the Passcode is .6*m=vQb. The number of available audio and web conference lines is 1,000. FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–6, Atlanta, Georgia 30329–4027; Telephone: (404) 639– 3423; Email: nchhstppolicy@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) is charged with advising the Secretary of Health and Human Services, the Director, CDC, and the Administrator, HRSA, regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and STD prevention and SUMMARY: PO 00000 Frm 00038 Fmt 4703 Sfmt 9990 treatment efforts including (1) surveillance; (2) epidemiologic, behavioral, health services, and laboratory research; (3) identification of policy issues and opportunities related to prevention and treatment including but not limited to professional education, healthcare delivery, social determinants of health, research, and prevention and treatment services; (4) strategic issues influencing the ability of CDC and HRSA to fulfill their missions; (5) development and implementation of federal programs focused on prevention and treatment; and (6) provide support to the agencies in their response to emerging health needs. Matters To Be Considered: The agenda will include discussions on (1) sexual health, (2) equitable scale-up of interventions, (3) mpox, and (4) youth and STD testing. Agenda items are subject to change as priorities dictate. Public Participation Written Public Comment: Members of the public are welcome to submit written comments in advance of the meeting. Written comments must be submitted by emailing nchhstppolicy@ cdc.gov with subject line ‘‘Spring CHAC Public Comment Registration’’ by April 28, 2023. Oral Public Comment: Individuals who would like to make an oral comment during the public comment period must register by emailing nchhstppolicy@cdc.gov with subject line ‘‘Spring CHAC Public Comment Registration’’ by April 4, 2023. The public comment period is on April 18, 2023, 3:45 p.m., EDT. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–04044 Filed 2–27–23; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 88, Number 39 (Tuesday, February 28, 2023)]
[Notices]
[Page 12684]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04044]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) and the Health Resources and 
Services Administration (HRSA) announce the following meeting for the 
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention 
and Treatment (CHAC). This meeting is open to the public, limited only 
by the number of audio and web conference lines (1,000 audio and web 
conference lines are available). Members of the public are welcome to 
listen to the meeting by accessing the telephone number and web access 
provided in the addresses section below. Time will be available for 
public comment (registration is required to provide oral comment).

DATES: The meeting will be held on April 18 and 19, 2023, from 9 a.m. 
to 4:30 p.m., EDT. Written comments must be submitted by April 28, 
2023. Registration to make oral comments must be submitted by April 4, 
2023.

ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID: 
160 343 1340, and the Passcode is 59009399. The web conference access 
is https://cdc.zoomgov.com/j/1603431340?pwd=VnB3SmRrRFA0OWF2bUpVMGgzbW51QT09, and the Passcode is 
.6*m=vQb. The number of available audio and web conference lines is 
1,000.

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, 
CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 30329-4027; 
Telephone: (404) 639-3423; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The CDC/HRSA Advisory Committee on HIV, Viral Hepatitis 
and STD Prevention and Treatment (CHAC) is charged with advising the 
Secretary of Health and Human Services, the Director, CDC, and the 
Administrator, HRSA, regarding objectives, strategies, policies, and 
priorities for HIV, viral hepatitis, and STD prevention and treatment 
efforts including (1) surveillance; (2) epidemiologic, behavioral, 
health services, and laboratory research; (3) identification of policy 
issues and opportunities related to prevention and treatment including 
but not limited to professional education, healthcare delivery, social 
determinants of health, research, and prevention and treatment 
services; (4) strategic issues influencing the ability of CDC and HRSA 
to fulfill their missions; (5) development and implementation of 
federal programs focused on prevention and treatment; and (6) provide 
support to the agencies in their response to emerging health needs.
    Matters To Be Considered: The agenda will include discussions on 
(1) sexual health, (2) equitable scale-up of interventions, (3) mpox, 
and (4) youth and STD testing. Agenda items are subject to change as 
priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing [email protected] with subject line ``Spring 
CHAC Public Comment Registration'' by April 28, 2023.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
[email protected] with subject line ``Spring CHAC Public Comment 
Registration'' by April 4, 2023. The public comment period is on April 
18, 2023, 3:45 p.m., EDT.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04044 Filed 2-27-23; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.